After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

PREPARE: Strengthening Regulatory, Ethics, and Pharmacovigilance Systems for Health Preparedness in Sub-Saharan Africa

PREPARE – Pharmacovigilance, Regulatory and Ethics Preparedness and Response Innovation Network – is one of the newest proposal that we submitted to the European Commission under the Global Health EDCTP3 programme.

Read More

PRECISION-asympTB – Proposal submitted to EDCTP3 call for innovative TB treatment research in sub-Saharan Africa

PRECISION-asympTB was submitted under the EDCTP3 2026 Call on Tuberculosis.  Despite decades of global efforts, TB remains one of the leading infectious causes of death worldwide. One of the greatest challenges today

Read More

ITAIL-COVID-19 Project second press release

Summarising the latest most important achievements, the project ITAIL-COVID-19 (Integrated Testing Approaches and Intensive Laboratory training as strategy against COVID-19) second press release is now available: click here to download.

Read More